Fact-checked by Grok 2 weeks ago

Silent mutation

A silent mutation, also known as a synonymous mutation, is a type of point mutation in the DNA sequence that changes a codon but does not alter the amino acid specified by that codon during protein translation, owing to the redundancy or degeneracy of the genetic code.^[1] These mutations typically occur in the third position of a codon, often called the wobble position, where multiple nucleotides can encode the same amino acid without affecting the protein's primary structure.^[2] Historically viewed as selectively neutral with no functional consequences, silent mutations have been recognized in recent research to potentially influence various cellular processes beyond protein sequence. For instance, they can affect mRNA stability, splicing efficiency, translation kinetics, and interactions with microRNAs, thereby modulating gene expression levels or even protein folding indirectly.^[3] Such effects arise because synonymous changes may alter the speed of ribosome movement during translation or disrupt regulatory elements within exons. In evolutionary biology, silent mutations contribute to genetic variation without immediate fitness costs, serving as a reservoir for potential adaptive changes, though their accumulation can signal hypermutability in contexts like cancer.^[4] Studies indicate that many silent mutations are not truly neutral but can be deleterious, impacting organismal fitness by subtly perturbing protein production or function.^[5] In human disease, certain silent mutations have been implicated in pathologies such as cancer, where they may drive oncogenesis by altering splicing or expression of key genes, including roles in KRAS-mutant tumors affecting therapeutic resistance as of 2024.^[3]^[6]

Fundamentals

Definition and Types

A silent mutation, also known as a synonymous mutation or silent substitution, is a type of point mutation in the DNA sequence that alters a codon but results in the same amino acid being incorporated during protein translation, due to the redundancy inherent in the genetic code.^[7] This change does not directly modify the primary amino acid sequence of the resulting protein, distinguishing it from other point mutations that affect protein structure.^[2] Silent mutations were first identified in the early 1960s as researchers, including Marshall Nirenberg and J. Heinrich Matthaei, deciphered the genetic code through experiments demonstrating how specific nucleotide triplets direct amino acid assembly.^[8] The term "silent" emerged to describe these mutations' apparent neutrality, as they were observed to produce no immediate change in the protein's amino acid composition or the organism's phenotype under initial analyses.^[9] These mutations primarily occur as base substitutions within codon families that share the same amino acid specificity, often at the third nucleotide position (the wobble base), where such changes do not disrupt the codon's meaning—for example, substituting CTT (leucine) with CTC (also leucine).^[10] In contrast, missense mutations substitute one amino acid for another, potentially altering protein function, while nonsense mutations introduce a premature stop codon, truncating the protein.^[11] Representative examples include the glycine codons GGU, GGC, GGA, and GGG, any substitution among which qualifies as silent.^[7] This phenomenon arises briefly from the degeneracy of the genetic code, allowing multiple codons to encode identical amino acids.^[12]

Relation to the Genetic Code

The genetic code comprises 64 distinct codons, arising from the 4³ possible combinations of the four nucleotide bases (adenine, uracil, guanine, and cytosine) in messenger RNA, which collectively specify the 20 standard amino acids along with 3 stop codons that terminate protein synthesis.^[13] This structure exhibits degeneracy, whereby multiple codons can encode the same amino acid, with the redundancy most pronounced in the third nucleotide position of the codon.^[13] The wobble hypothesis, formulated by Francis Crick in 1966, accounts for this pattern by proposing that the base-pairing between the third codon position and the first anticodon position in transfer RNA allows for non-standard pairings, such as guanine-uracil or inosine-uracil, thereby reducing the number of required tRNA species while accommodating codon variability.^[14] In the degenerate genetic code, most of the 20 amino acids are represented by 2 to 6 synonymous codons, permitting silent mutations—nucleotide substitutions that do not change the specified amino acid—to occur frequently, particularly through alterations at the third position.^[15] For instance, the codons UUU and UUC both encode phenylalanine, so a C-to-U change at the third position in UUC would constitute a silent mutation under the standard code.^[16] This synonymy arises because the code evolved to minimize the impact of certain point mutations, ensuring that changes in the third position often preserve the amino acid identity.^[17] The standard genetic code is conventionally organized into a tabular format with 16 boxes, each encompassing four codons that vary solely in their third nucleotide; within many of these boxes, the four codons are synonymous, encoding the same amino acid and illustrating the clustered nature of degeneracy.^[18] Eight such boxes contain fully synonymous sets for amino acids like alanine (GCN) or proline (CCN), where N denotes any of the four bases, while others split into pairs or include stop signals, further delineating the code's structured redundancy.^[19] Although the standard genetic code predominates in most organisms, variant codes exist in specific lineages, such as vertebrate mitochondria—where UGA encodes tryptophan instead of serving as a stop codon—and ciliate nuclear genomes—where UAA and UAG code for glutamine rather than termination—potentially redefining synonymous codon relationships and the occurrence of silent mutations in those systems.^[19] These non-standard codes, documented across diverse taxa, highlight deviations from the universal degeneracy pattern while maintaining overall functionality in translation.^[20]

Molecular Mechanisms

Codon Usage Bias

Codon usage bias refers to the non-random and preferential selection of synonymous codons within the coding sequences of genes, a phenomenon observed across diverse organisms including bacteria, plants, and animals. This bias manifests as unequal frequencies among the multiple codons that encode the same amino acid, influenced by factors such as the organism's genome composition and expression demands. In highly expressed genes, for instance, there is a tendency to favor "optimal" codons that align with abundant tRNA species to enhance translational efficiency.^[21] The primary causes of codon usage bias include the availability of tRNA molecules and the need to optimize translation efficiency, where preferred codons correspond to more abundant isoacceptor tRNAs, thereby accelerating ribosome movement during protein synthesis. Mutational pressures and selection for rapid translation in essential genes further contribute to this pattern, particularly in prokaryotes where efficient decoding minimizes ribosomal pausing. To quantify this bias, researchers employ indices such as the Codon Adaptation Index (CAI), which measures the similarity of a gene's codon usage to that of highly expressed reference genes on a scale from 0 to 1, with higher values indicating stronger adaptation for efficient translation. Another common metric is the Effective Number of Codons (ENC), which ranges from 20 (extreme bias) to 61 (no bias) and assesses the deviation from equal usage of synonymous codons across a gene.^[22]^[23]^[24]^[25] Examples of codon usage bias are evident in various systems; in humans, GC-rich codons are often preferred in genes with high GC content, driven by GC-biased gene conversion and local recombination rates that favor codons ending in G or C. In bacterial operons, such as those in Escherichia coli, there is a pronounced bias toward codons that enable rapid translation, reflecting selection for high expression in polycistronic messages. Silent mutations that alter a codon to a rare synonymous variant can disrupt this bias, potentially slowing translation elongation by causing ribosomal stalling due to scarce tRNAs or reducing decoding accuracy through increased error rates at suboptimal sites.^[21]^[26]^[27]^[28]

Impacts on mRNA Processing and Translation

Silent mutations, also known as synonymous mutations, can influence translation dynamics by altering codon usage, which affects the speed and accuracy of protein synthesis. Rare codons introduced by these mutations cause ribosome pausing during elongation, potentially leading to suboptimal co-translational protein maturation.^[29] These mutations also impact pre-mRNA splicing by disrupting exonic splicing enhancers (ESEs) or silencers (ESSs), which are regulatory sequences within exons that guide spliceosome assembly. A synonymous variant may abolish an ESE binding site for splicing factors like SRSF1, resulting in exon skipping or activation of cryptic splice sites, thereby producing aberrant transcripts. Experimental minigene assays have shown that approximately 50% of tested synonymous driver mutations in cancer oncogenes alter splicing efficiency, with effects enriched near exon boundaries.^[30] In oncogenes such as TP53 and JAK2, such mutations have been identified as drivers in cancer by shifting splicing patterns, reducing functional protein output by 30-50% in affected cells.^[30] Beyond splicing, silent mutations can modify mRNA secondary structure, influencing stability, degradation rates, and nuclear export. Changes in folding stability, quantified by free energy calculations (e.g., a 1-7 kcal/mol shift), often reduce mRNA half-life by destabilizing stem-loops that protect against endonucleases or impair export factor binding. Model system experiments, including actinomycin D chase assays in human cell lines, reveal that synonymous variants can decrease mRNA half-life, correlating with lower steady-state levels and protein expression.^[31] A notable example occurs in the CFTR gene, where synonymous mutations in exon 12 disrupt ESE motifs, causing substantial exon skipping and severe splicing defects that manifest as cystic fibrosis phenotypes, including reduced chloride channel function.^[32] These effects highlight how silent changes propagate through mRNA processing pathways to alter gene output.

Biological Consequences

Effects on Protein Folding and Function

Silent mutations exert indirect effects on protein folding and function primarily through their influence on translation dynamics, particularly co-translational folding processes. During protein synthesis, the ribosome translates mRNA in a codon-specific manner, and synonymous substitutions can alter the speed of this process by favoring optimal or suboptimal codons relative to tRNA availability. Slower translation elongation, often resulting from rare codons, provides additional time for the nascent chain to form correct local structures and inter-domain interactions as it emerges from the ribosome, thereby minimizing misfolding risks. Conversely, rapid translation may trap the protein in non-native conformations, leading to aggregation or impaired function. This sensitivity to translation timing is especially critical for multi-domain proteins, where premature domain closure can disrupt overall architecture. A well-documented example involves a silent mutation in the p53 tumor suppressor gene at codon 22 (c.65C>T, L22L), which changes the codon from CTG to CTT without altering the leucine residue. This substitution reduces the affinity of p53 mRNA for the E3 ubiquitin ligase MDM2 and impairs the recruitment of ATM kinase to polysomes. Consequently, co-translational phosphorylation at serine 15 is inhibited by approximately 50%, leading to enhanced MDM2-mediated ubiquitination and degradation of the nascent p53 protein, thereby compromising its stability and DNA damage response function. Although the primary amino acid sequence remains unchanged, this mutation alters the folding kinetics indirectly by affecting post-translational modifications during synthesis, resulting in a less stable and functional protein.^[33] Beyond specific modifications, silent mutations can induce broader functional impacts by shifting folding pathways, which may alter enzyme kinetics or introduce allosteric effects despite identical primary sequences. For instance, differences in translation speed can lead to variations in the population of folded states, affecting active site geometry or ligand binding affinity and thus catalytic efficiency. In cases where synonymous changes influence splicing enhancers, they may promote alternative isoform production with subtly different folding propensities, further modulating protein activity. These effects highlight how synonymous variants can propagate to allosteric sites, enabling regulatory fine-tuning without sequence alterations.^[34] Empirical evidence underscores the prevalence of these disruptions, as demonstrated by a 2022 study from the University of Michigan involving genome editing in 21 essential yeast genes. Researchers constructed over 8,000 synonymous mutants and found that 75.9% exhibited strongly deleterious fitness effects comparable to nonsynonymous mutations, with mechanisms including altered translation elongation rates that perturb co-translational folding and lead to misfolded or unstable proteins in yeast models.^[35]

Influence on Gene Expression

Silent mutations, by altering synonymous codons within coding sequences, can influence gene expression through regulatory mechanisms that affect mRNA stability and translational efficiency. Specifically, these mutations may disrupt or enhance microRNA (miRNA) binding sites within the coding region, leading to changes in mRNA degradation or repression of translation. For instance, a synonymous substitution in the IRGM gene creates a binding site for miR-196, resulting in increased mRNA degradation and reduced gene expression, which has been implicated in Crohn's disease pathogenesis.^[36] Synonymous mutations also impact overall expression levels by modulating translation efficiency, often through codon usage bias that affects ribosome speed and mRNA secondary structure. Rare codons can cause ribosome pausing, reducing protein output; in reporter gene assays using green fluorescent protein (GFP) variants in Escherichia coli, synonymous changes led to up to a 250-fold variation in protein levels, with many variants showing 10- to 100-fold reductions due to altered mRNA folding near the start codon.^[37] In eukaryotic systems, such as human cells, similar effects have been observed, where suboptimal codon choices decrease translation rates and lower steady-state protein levels by 20-50% in luciferase reporter constructs.^[38] Tissue-specific effects arise from variations in codon usage bias across cell types, which fine-tune expression patterns, particularly for developmental genes. In humans, genes highly expressed in specific tissues, like brain or liver, exhibit distinct synonymous codon preferences that correlate with local tRNA abundances, enabling differential translation efficiency.^[39] For example, testis-specific genes in Drosophila show enriched rare codons that restrict expression to germ cells, preventing ectopic activity in somatic tissues.^[40] Quantitative models highlight how mutation-induced ribosome pausing contributes to expression variance, with slower elongation at synonymous sites increasing stochastic fluctuations in protein output by up to 30% in yeast reporter systems.^[41] These pausing events, often linked to rare codons, can briefly reference prior mRNA processing alterations like altered secondary structure, amplifying overall regulatory impacts on gene expression patterns. Recent studies (as of 2024) have also shown that silent mutations can influence expression of neighboring genes by altering chromatin structure or transcription, with implications for diseases like cancer.^[42] In cancer, silent mutations in KRAS can affect splicing and tumor progression.^[6]

Evolutionary Aspects

Neutrality in Molecular Evolution

The neutral theory of molecular evolution, proposed by Motoo Kimura in 1968, posits that the majority of evolutionary changes at the molecular level result from random genetic drift of selectively neutral mutations rather than adaptive natural selection.^[43] Under this framework, silent mutations, which do not alter the amino acid sequence of proteins due to the degeneracy of the genetic code, are considered prototypically neutral and accumulate primarily through drift.^[43] These mutations serve as markers of the underlying neutral mutation rate, providing a baseline for understanding evolutionary processes without the confounding effects of selection on protein function. Silent mutations accumulate at the synonymous substitution rate, denoted as d_S, which reflects the rate of neutral evolution and can be used to estimate overall divergence times between species.^[44] In comparisons of genetic drift versus selection, the ratio d_S / d_N (where d_N is the nonsynonymous substitution rate) is typically greater than 1, indicating strong purifying selection acting on nonsynonymous sites to conserve protein structure and function, while synonymous sites evolve more freely under drift.^[45] Silent sites thus provide a neutral reference for calibrating evolutionary clocks and inferring divergence, as their substitution rate approximates the mutation rate in the absence of selection.^[46] In viral evolution, such as that of HIV-1, silent mutations often track neutral processes, accumulating via drift in non-coding or degenerate regions without impacting viral fitness.^[47] Genome-wide scans across eukaryotic genomes similarly reveal that approximately 75-80% of synonymous sites evolve neutrally, with the remainder potentially influenced by weak selective constraints, underscoring the dominant role of drift in synonymous evolution.^[48] The synonymous substitution rate d_S is calculated as the number of synonymous substitutions per potential synonymous site, corrected for multiple hits to account for unobserved changes over time. To derive this, first compute the observed proportion of synonymous differences p_s, defined as the number of synonymous nucleotide differences divided by the total number of comparable synonymous sites between two aligned sequences (where the number of synonymous sites L per codon is determined by the genetic code's degeneracy, averaging about 2.25 per codon across all codons). For low divergence, d_S \approx p_s, but for higher divergence, apply a correction such as the Jukes-Cantor model adapted for synonymous sites:

d_S = -\frac{3}{4} \ln \left(1 - \frac{4}{3} p_s \right)

This formula assumes equal mutation rates among nucleotides and corrects for multiple substitutions at the same site, with the $3/4 factor arising from the three possible alternative nucleotides and the logarithmic term estimating the true number of events from the observed proportion p_s.^[46] The full derivation starts from the Poisson process of substitutions, where the probability of no change at a site is e^{-\lambda t} (with \lambda the mutation rate and t time), leading to p = 1 - e^{-\lambda t} for observed differences under a simple model, and thus \lambda t = -\ln(1 - p); extending to four nucleotides with equal rates yields the Jukes-Cantor form.^[44]

Selection Pressures and Population Genetics

Silent mutations, while often considered neutral, are subject to weak purifying and positive selection pressures, particularly through codon usage bias that optimizes translation efficiency. In species like Drosophila, synonymous changes adapt to preferred codons, enhancing protein synthesis accuracy and speed, as evidenced by non-random codon usage patterns across genes with varying expression levels.^[49] Studies in D. melanogaster demonstrate that selection favors codons matching abundant tRNAs, with synonymous site polymorphism reduced in highly expressed genes, indicating purifying selection against suboptimal variants.^[50] This selection challenges the assumption of complete neutrality, showing how silent mutations can influence fitness via translational efficiency. In population genetics, the allele frequency spectra of synonymous variants deviate from neutral expectations, with an excess of rare alleles reflecting purifying selection and a depletion of common variants under constraint.^[51] For instance, synonymous variants exhibit skewed spectra toward lower frequencies compared to intergenic sites, consistent with weak negative selection removing deleterious changes.^[52] Additionally, silent mutations often occur in linkage disequilibrium with functional sites, where hitchhiking effects amplify their population dynamics; in human genomes, synonymous variants show negative LD with deleterious missense mutations, mitigating overall genetic interference.^[53] These patterns highlight how drift and selection interact at synonymous sites across populations. In human genetics, genome-wide association studies (GWAS) have identified synonymous single nucleotide polymorphisms (SNPs) linked to complex traits, often through indirect effects on gene expression rather than protein sequence. Theoretical models quantify this selection, estimating coefficients for codon bias on the order of s ≈ 0.01, balancing mutation, drift, and weak purifying forces to maintain optimal usage without overwhelming genetic load.^[54] Silent mutations contribute to overall genetic load by accumulating mildly deleterious effects on translation and expression, with population-level simulations showing they account for a non-negligible fraction of fitness decline, especially in large effective population sizes. This integration of silent variants into evolutionary models refines predictions of molecular adaptation and disease risk.

Research and Clinical Relevance

Role in Cancer Pathogenesis

Silent mutations, also known as synonymous mutations, constitute approximately 20-25% of somatic point mutations identified in cancer genomes across various tumor types, yet they are often dismissed as neutral passengers in genomic sequencing analyses due to their lack of amino acid change.^[55]^[56] Recent analyses, including those from 2023-2024, suggest that 6-20% of these synonymous variants may function as driver events, contributing to oncogenesis by influencing regulatory processes rather than direct protein alteration.00145-7)^[3] In cancer-specific contexts, synonymous mutations within oncogenes like KRAS exemplify their pathogenic potential; for instance, the G12G variant (c.36T>C) enhances KRAS mRNA translation efficiency and protein expression, thereby promoting cell proliferation and tumor invasiveness in models such as NIH3T3 cells.^[6] Similarly, the G60G silent mutation (c.180T>A/C/G), when co-occurring with the Q61K mutation, masks a cryptic splice donor site to prevent aberrant splicing, enabling production of full-length oncogenic KRAS Q61K isoforms and driving tumorigenesis in RAS-mutant tumors.^[57] These alterations underscore how silent changes can indirectly amplify oncogenic signaling without modifying the protein sequence. Tumor microenvironment factors, such as hypoxia, further amplify the impact of silent mutations by enhancing mRNA stability and expression of key genes; for example, synonymous variants can disrupt N6-methyladenosine (m6A) modifications, stabilizing oncogenic transcripts in low-oxygen conditions prevalent in solid tumors.^[58] The Cancer Genome Atlas (TCGA) datasets reveal silent mutations in tumor suppressor genes like TP53 that correlate with altered expression levels, often through splicing interference near exon-intron boundaries, thereby impairing p53 function and facilitating genomic instability in cancers such as breast and ovarian tumors.00145-7)^[59] Emerging 2024 research on RAS family genes highlights silent mutations' contribution to therapeutic resistance, where they sustain elevated protein levels despite targeted inhibitors, as seen in KRAS-mutant lung and pancreatic cancers.^[6] A 2023 study published in Scientific Reports further links silent mutations to metastatic progression by altering codon optimality, which influences protein folding kinetics and enhances tumor cell adaptability during dissemination.^[3] These findings emphasize the need to re-evaluate silent variants as overlooked contributors to cancer pathogenesis.

Applications in Drug Resistance and Therapeutics

Silent mutations have significant implications in drug resistance, particularly through their influence on the expression of multidrug resistance genes. In the ABCB1 (MDR1) gene, which encodes the P-glycoprotein efflux pump responsible for expelling chemotherapeutic agents from cells, the synonymous polymorphism 3435C>T (rs1045642) alters mRNA stability and folding, leading to reduced protein expression and activity.^[60] This variant has been associated with decreased drug efflux, potentially improving chemotherapy response in cancers such as breast and lung, where homozygous TT carriers exhibit lower P-gp levels and better outcomes with agents like docetaxel.^[61]^[62] Similar silent polymorphisms in ABCB1 contribute to variable pharmacokinetics of irinotecan and other substrates, highlighting their role in modulating resistance phenotypes without changing the amino acid sequence.^[63] In diagnostics, silent single nucleotide polymorphisms (SNPs) serve as valuable biomarkers for personalized medicine by predicting drug response and disease risk. Next-generation sequencing (NGS) panels increasingly incorporate synonymous variants to assess pharmacogenomic profiles, as these SNPs can affect splicing, translation efficiency, and overall gene expression.^[64] For instance, silent SNPs in ADME-related genes like ABCB1 are analyzed in NGS-based assays to stratify patients for chemotherapy toxicity and efficacy, enabling tailored dosing in oncology.^[65] This approach extends to broader applications, where silent variants in population cohorts inform risk prediction models for adverse drug reactions.^[66] Therapeutic strategies leverage silent mutations to enhance gene therapy outcomes, with codon optimization designed to boost expression while mitigating unintended effects. In vector-based gene therapies, synonymous codon changes are used to match host preferences, but pitfalls such as altered mRNA secondary structure or increased immunogenicity from over-optimization can reduce efficacy and safety.^[67] Recent advances employ careful synonymous engineering to avoid these issues, as seen in AAV-delivered therapeutics where balanced codon usage preserves native folding and minimizes immune responses.^[68] In cancer, CRISPR-based editing targets silent drivers without off-target effects. Beyond clinical settings, silent mutations find applications in synthetic biology for cellular tracking and engineering. Researchers encode barcodes via in-frame synonymous substitutions in essential genes, enabling lineage tracing without perturbing protein function, as demonstrated in TRACE-Seq for monitoring heterogeneous tumor populations.^[69] In evolutionary engineering, directed selection favors beneficial synonymous changes that enhance fitness, such as those improving translation speed or mRNA stability in microbial strains for biofuel production.^[70] These approaches underscore the utility of silent variants in designing robust synthetic circuits and adaptive populations.^[71]

References

[1]
silent mutation | Learn Science at Scitable - Nature
A mutation where a change in a DNA codon does not result in a change in amino acid translation.
[2]
Silent Mutation - an overview | ScienceDirect Topics
Silent mutations are DNA changes that don't alter the amino acid sequence of a protein, often occurring in the 'wobble' nucleotide of a codon.
[3]
Possible involvement of silent mutations in cancer pathogenesis and ...
May 10, 2023 · Silent mutations can affect on protein levels or conformation by modifying mRNA stability, miRNA binding sites, translation efficiency or ...
[4]
Hypermutability and silent mutations in human carcinogenesis
Silent mutations are nucleotide changes without amino acid change. High silent mutation frequency in tumors indicates hypermutability, and some tumors may be ...
[5]
Study: Most 'silent' genetic mutations are harmful, not neutral, a ...
Jun 8, 2022 · University of Michigan biologists show that most synonymous mutations are strongly harmful. The strong nonneutrality of most synonymous ...Missing: definition | Show results with:definition<|control11|><|separator|>
[6]
Silent mutation - Definition and Examples - Biology Online Dictionary
Nov 13, 2022 · A silent mutation (quiet mutation) is a form of mutation that does not cause a major change in the amino acid. As a result, the protein remains active and ...Silent Mutation Definition · Cause of Silent Mutation · Silent Mutation Examples
[7]
[PDF] Marshall Nirenberg - Nobel Lecture
The genetic code is shown in Fig. 3. Most triplets correspond to amino acids. Codons for the same amino acid usually differ only in the base occupy- ing the ...
[8]
Disproving a 60-Year-Old Hypothesis: Most “Silent” Mutations Are ...
Aug 21, 2022 · Marshall Nirenberg, a University of Michigan alumni, and a small group of researchers cracked the genetic code of life in the early 1960s, ...
[9]
Types of mutations - Understanding Evolution
These are called silent mutations. change an amino-acid-coding codon to a single “stop” codon and cause an incomplete protein. This can have serious effects ...
[10]
Silent Mutation - an overview | ScienceDirect Topics
A silent mutation is a DNA change that doesn't alter the protein sequence, as it changes to a different codon for the same amino acid.
[11]
The genetic code - PMC - NIH
Apr 22, 2014 · Nirenberg reported the first decoded amino acid, based on the finding that poly-uracil RNA incorporated only phenylalanine, in the classic 1961 ...
[12]
mRNA code and translation (article) - Khan Academy
With 64 possible codons and only 20 amino acids, many amino acids are encoded by more than one codon. This redundancy mainly occurs at the third nucleotide ...
[13]
Codon—anticodon pairing: The wobble hypothesis - ScienceDirect
This hypothesis is explored systematically, and it is shown that such a wobble could explain the general nature of the degeneracy of the genetic code.Missing: original | Show results with:original
[14]
6.3: Genetic Code - Biology LibreTexts
May 14, 2022 · The RNA Codons. Second nucleotide. U, C, A, G. U, UUU Phenylalanine (Phe), UCU Serine (Ser), UAU Tyrosine (Tyr), UGU Cysteine (Cys), U. UUC Phe ...
[15]
The Information in DNA Determines Cellular Function via Translation
For example, the amino acid phenylalanine (Phe) is specified by the codons UUU and UUC, and the amino acid leucine (Leu) is specified by the codons CUU, CUC, ...
[16]
Celebrating wobble decoding: Half a century and still much is new
Sixty-one of 64 3-nucleoside codons of the mRNA, N1N2N3, are decoded in frame with a complementary sequence of the tRNA anticodon, N34N35N36. Three codons are ...
[17]
Coevolution Theory of the Genetic Code at Age Forty
The 64 codons in the genetic code are divided into 16 four-codon boxes. Wobble base pairings enable the reading of the four codons in any box by using less ...
[18]
Genetic Codes - NCBI
Currently, genetic codes can be set independently for nucleus, mitochondria ... The ciliate macronuclear code has not been determined completely. The codon ...The Mold, Protozoan, and... · The Invertebrate Mitochondrial... · Rhabdopleuridae...
[19]
Non-Standard Genetic Codes Define New Concepts for Protein ...
Nov 10, 2015 · Ciliates that use UAR as sense codons terminate translation only at UGA codons and their eRF1 is UGA specific. Introduction of the divergent YCF ...Missing: silent | Show results with:silent
[20]
Codon usage bias - PMC - PubMed Central - NIH
Nov 25, 2021 · Codon usage bias is the preferential or non-random use of synonymous codons, a ubiquitous phenomenon observed in bacteria, plants and animals.Missing: seminal | Show results with:seminal
[21]
Review Codon Bias as a Means to Fine-Tune Gene Expression
Jul 16, 2015 · It is generally accepted that codon bias contributes to translation efficiency by tuning the elongation rate of the process.
[22]
Codon usage bias from tRNA's point of view - NIH
We show that as minimal generation times get shorter, the genomes contain more tRNA genes, but fewer anticodon species.
[23]
The codon adaptation index-a measure of directional synonymous ...
Abstract. A simple, effective measure of synonymous codon usage bias, the Codon Adaptation Index, is detailed. The index uses a reference set of highly exp.Missing: original | Show results with:original
[24]
The 'effective number of codons' used in a gene - ScienceDirect.com
A simple measure is presented that quantifies how far the codon usage of a gene departs from equal usage of synonymous codons.Missing: original | Show results with:original
[25]
Variation in the strength of selected codon usage bias among bacteria
Among bacteria, genomic G+C content varies over a wide range, presumably reflecting variation in mutation biases (7), with a major impact on codon usage (8). In ...Sequence Data · Phylogenetic Analyses · Discussion
[26]
A code within the genetic code: codon usage regulates co ...
Sep 9, 2020 · A growing body evidence now shows that codon usage regulates protein structure and gene expression through effects on co-translational protein folding.
[27]
Preferred synonymous codons are translated more accurately
Jul 6, 2022 · Eighteen of the 20 amino acids are each encoded by more than one codon, but the synonymous codons are usually used unequally in a genome (1, 2).
[28]
https://www.science.org/doi/10.1126/sciadv.abl9812
[29]
https://doi.org/10.1016/j.jmb.2012.06.010
[30]
https://doi.org/10.1016/j.cell.2014.01.051
[31]
https://doi.org/10.1126/science.1131262
[32]
A single synonymous mutation determines the phosphorylation and ...
A single synonymous mutation in p53 codon 22 (L22L) prevents the phosphorylation of the nascent p53 protein and the stabilization of p53 following genotoxic ...
[33]
Synonymous codon substitutions perturb cotranslational protein ...
Here we show that synonymous mRNA mutations can alter a protein folding mechanism in vivo, leading to changes in cellular fitness. This work demonstrates that ...
[34]
The conserved Phe GH5 of importance for hemoglobin intersubunit ...
Mar 21, 2014 · ... synonymous mutations alter hemoglobin function and likely confer an adaptive advantage. In protein coding genes, the ratio (ω) between non ...<|control11|><|separator|>
[35]
Selection on Synonymous Sites for Increased Accessibility around ...
Apr 4, 2012 · Recent evidence suggests that microRNA (miRNA) function may affect synonymous codon choices near miRNA target sites.
[36]
Coding-Sequence Determinants of Gene Expression in Escherichia coli
### Summary of Quantitative Examples of Synonymous Mutations Affecting Gene Expression
[37]
Synonymous but not the same: the causes and consequences of ...
Nov 23, 2010 · Translationally efficient codons may increase elongation rate, accuracy or both. Rapid elongation should not be expected to influence protein ...
[38]
Tissue-specific codon usage and the expression of human genes
Our findings suggest that codon-mediated translational control may play an important role in the differentiation and regulation of tissue-specific gene products ...
[39]
Distinct responses to rare codons in select Drosophila tissues - eLife
May 6, 2022 · We find that reporter protein expression declines drastically over a narrow range of rare codon usage in a gene. We further show that specific ...
[40]
Synonymous Mutations and Ribosome Stalling Can Lead to Altered ...
Here we propose that long-enough ribosomal pause time-scales may lead to alternate folding pathways and distinct minima on the folding free energy surface.
[41]
Evolutionary Rate at the Molecular Level - Nature
Article; Published: 17 February 1968. Evolutionary Rate at the Molecular Level. MOTOO KIMURA. Nature volume 217, pages 624–626 (1968)Cite this article. 16k ...
[42]
Estimating Synonymous and Nonsynonymous Substitution Rates ...
The numbers of synonymous and nonsynonymous substitutions per site are then dS = tρ*S/(3ρ1S) and dN = tρ*N/(3ρ1N), respectively (see Table 1 ). A New ...Abstract · Introduction · Methods for Estimating... · Comparison of Methods for...
[43]
The Relationship between dN/dS and Scaled Selection Coefficients
Under neutral evolution, we expect that d N / d S = 1 , and as purifying selection increases in strength, dN/dS should correspondingly decrease. Therefore, we ...
[44]
Simple Methods for Estimating the Numbers of Synonymous and ...
Of course, this method gives only approximate estimates of ds and dN because, strictly speaking, the Jukes-Cantor formula does not apply at some silent ...
[45]
Counterintuitive Evolution of HIV during Childhood Infection
If silent mutations and mid-frequency polymorphisms are selectively neutral, and deleterious mutations are confined to the low frequency range, then the ...<|separator|>
[46]
Interpreting mammalian synonymous site conservation in light ... - NIH
Feb 27, 2025 · Around 20% of synonymous sites are conserved in placental mammal genomes, but the evolutionary forces determining this is unclear. This study ...
[47]
Evolution of codon usage bias in Drosophila - PNAS
Jul 22, 1997 · Therefore, unequal usage of synonymous codons must be due to either mutation bias or selection. Drosophila has served as a model ...
[48]
Strong Purifying Selection at Synonymous Sites in D. melanogaster
Codon bias is generally thought to be the product of background substitution biases combined with a weak selective force within genes skewing codon usage ...<|control11|><|separator|>
[49]
The mutational constraint spectrum quantified from variation ... - Nature
May 27, 2020 · As natural selection purges deleterious variants from human populations, methods to detect selection have modelled the reduction in variation ( ...<|control11|><|separator|>
[50]
Context-dependent and -independent selection on synonymous ...
Apr 28, 2021 · Linkage disequilibrium (LD) usually causes the non-independent frequency spectrum of neighboring mutations. It is necessary to cancel the effect ...
[51]
Defining the role of common variation in the genomic and biological ...
We explored whether the height-associated SNPs were in strong LD (r 2 >0.8) with non-synonymous coding variants in 1000 Genomes Project CEU Phase 1 data.
[52]
In silico methods for predicting functional synonymous variants
May 22, 2023 · In this review, we discuss tools that should be used to investigate synonymous variants. We provide supportive examples from seminal studies.Missing: paper | Show results with:paper
[53]
Estimating Selection Intensity on Synonymous Codon Usage in a ...
Codon usage bias is the nonrandom use of synonymous codons for the same amino acid. Most population genetic models of codon usage evolution assume that the ...
[54]
Silent Mutations Make Some Noise - ScienceDirect.com
Mar 13, 2014 · The mechanism by which synonymous mutations are able to alter oncogene activity, modulation of the splicing machinery, may open avenues for ...
[55]
The dark matter of the cancer genome: aberrations in regulatory ...
In cancer, synonymous mutations are estimated to account for 20% of all point mutations, 6–8% of which are selected for and therefore may act as driver ...Regulatory Elements · Synonymous Mutations · Non‐coding Rnas<|separator|>
[56]
Role of silent mutations in KRAS-mutant tumors - PMC - NIH
Dec 10, 2024 · Silent mutations within the RAS gene have garnered increasing attention for their potential roles in tumorigenesis and therapeutic strategies.
[57]
Role of silent mutations in KRAS-mutant tumors
Silent mutations within the RAS gene have garnered increasing attention for their potential roles in tumorigenesis and therapeutic strategies.Regulation Of Kras Protein... · Kras-Mediated Upstream And... · Transcriptional And...<|separator|>
[58]
Synonymous mutations promote tumorigenesis by disrupting m6A ...
Apr 3, 2025 · The dynamic change of m6A has an influence on RNA stability, splicing, translation, and translocation and is orchestrated by a suite of “writers ...
[59]
TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and ...
The mutation spectrum of TP53 varied between the breast cancer subtypes, and individual alterations showed subtype-specific association. TP53 mutations were ...
[60]
The effect of ABCB1 polymorphisms on the outcome of breast ... - NIH
Apr 27, 2016 · Although the 3435C>T is a silent mutation, it has been shown to affect the expression and function of the P-gp in many ways. Studies have ...
[61]
The impact of ABCB1 gene polymorphism and its expression on non ...
Apr 10, 2020 · This study aimed to evaluate the association between the SNP 3435 and the expression of the ABCB1 gene in lung cancer patients in the Polish population.
[62]
The ABCB1 3435C > T polymorphism influences docetaxel ...
Sep 6, 2019 · P-gp was overexpressed in cells transfected with the ABCB1 3435C > T plasmid, leading to a significant increase in drug resistance to docetaxel.<|separator|>
[63]
Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with ...
Jun 15, 2007 · The authors investigated whether ABCB1, ABCC2, and ABCG2 genetic polymorphisms affect pharmacokinetics (PK) of irinotecan and treatment ...Abcb1, Abcc2, Abcg2... · Genotypes And Haplotypes · Discussion
[64]
Precision and Personalized Medicine: How Genomic Approach ...
The discovery of biomarkers that can be identified before the emergence of overt clinical symptoms, together with technological development, have paved the way ...
[65]
Analysis of genetic biomarkers, polymorphisms in ADME-related ...
Oct 19, 2023 · Here, we overview the impact of SNPs reported in various genes on the pharmacotherapy for PCa and evaluate current genetic biomarkers.Introduction · Prostate Cancer Biology · Pharmacogenomics And...
[66]
Silent SNPs: Impact on gene function and phenotype - ResearchGate
Aug 6, 2025 · Thus, silent SNPs should no longer be neglected in determining the likelihood of development of various diseases, and should be taken into ...
[67]
A critical analysis of codon optimization in human therapeutics - PMC
However, recent reports indicate that codon-optimization can affect protein conformation and function, increase immunogenicity, and reduce efficacy. We ...Missing: pitfalls | Show results with:pitfalls
[68]
Codon-optimization in gene therapy: promises, prospects and ...
This study provides a comprehensive review of the current metrics for codon-optimization, and its practical usage in research and clinical applications, in the ...Missing: pitfalls | Show results with:pitfalls
[69]
Highlight: HiFiCas9 Selectively Disables Mutant KRAS in Lung ...
Sep 3, 2025 · Using HiFi-Cas9, we designed guides that specifically recognise the two most common KRAS mutations in lung cancer, cutting only the mutant DNA ...
[70]
The TRACE-Seq method tracks recombination alleles and identifies ...
Barcoding HBB exon 1 with in-frame silent mutations preserves hemoglobin expression while allowing cell tracking within a heterogeneous population. To ...
[71]
Fitness benefits of a synonymous substitution in an ancient EF-Tu ...
We find that a synonymous mutation acquired on the gene encoding for EF-Tu is conditionally beneficial for bacterial fitness.
[72]
Unraveling the causes of adaptive benefits of synonymous ... - Nature
Jul 2, 2018 · These results suggest that synonymous mutations may have beneficial effects by increasing the expression of an enzyme with low substrate activity.